1. Gemcitabine: metabolism, mechanism of action, and self self-potentetion;Plunkett;Sem Oncol,1995
2. Mechanism of action of 2′,2′-difluorodeoxycytidine triphosphate on DNA synthesis;Huang;Proc Am Ass Cancer Res,1990
3. Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial;Blackstein;Oncology,2002
4. Phase II study of gemcitabine as first line chemotherapy in patients with advanced or metastatic breast cancer;Possinger;Anticancer Drugs,1999
5. Single agent gemcitabine is active in previously treated metastatic breast cancer;Spielmann;Oncology,2001